Psychiatric pharmacists have enaged in team-based care for 40+ years, and the research is overwhelmingly positive about their contribution to access, outcomes and cost. Given the diverse practice models in use today, you can find results of pharmacist contributions to most types of mental health practice settings. Below are some papers developed recently by AAPP committees and task forces that illustrate the broad impact that psychiatric pharmacists are having across the health care system.

The Role of Psychiatric Pharmacists

The Role of Board Certified Psychiatric Pharmacists in Expanding Access to Care and Improving Patient Outcomes

BCPPs currently assist in expanding care access, improving medication-related outcomes, and reducing health care costs by working collaboratively with physicians and other health care providers. However, they are often underutilized, which results in lost opportunities to better address the needs of persons with psychiatric or substance use disorders and to meet these needs in a timely manner. Five key areas in which BCPPs provide evidence-based care and could be more extensively used as a collaborative solution are: opioid use disorder, antipsychotic use among children, long-acting injectable antipsychotics, clozapine use, and transitions of care and care coordination. Continue reading.

Assessment of the current practice of psychiatric pharmacists in the United States

The current practice of psychiatric pharmacy is incredibly varied in terms of practice setting, activities performed, and services provided. This study is notable for being the first comprehensive survey of current psychiatric pharmacy practice in the United States. It illuminates the wide variety of practice settings that currently employ psychiatric pharmacists to improve access, outcomes, and cost. Continue reading.

Survey of prescriptive authority among psychiatric pharmacists in the United States

Psychiatric pharmacists experience a significant variability in their prescriptive authority. Their demographics reflect changes in residency accreditation and increased numbers of psychiatric residencies within VA facilities. Those with prescriptive authority reported treating psychiatric and medical conditions, creating added value. Expansion of psychiatric pharmacist services, including prescriptive authority, should be considered as a viable addition to the care provided to patients with mental illness, especially in areas where there is a shortage of such services. Continue reading.

The Impact of Psychiatric Pharmacists

Improving medication-related outcomes for patients with psychiatric and neurologic disorders: Value of psychiatric pharmacists as part of the health care team

In 2015, AAPP published this major paper that reviews the literature on psychiatric pharmacists' value up to 2014. Including summaries of 28 high-quality studies, it illustrates the value of psychiatric pharmacists in many different settings. This paper serves as a primer on psychiatric pharmacists by also reviewing the growing need for psychiatric pharmacists, the unique training and experience of the psychiatric pharmacist, and comprehensive medication management. Continue reading.

Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders

In 2020, AAPP conducted a literature review to update the list of key studies from the 2015 paper. The number of projects illustrates the expansion of psychiatric pharmacy practice and research since the previous paper was published. This paper provides summaries of 64 additional studies 1/1/2014-6/1/2019, as well as additional analysis of the outcomes. Continue reading.